To identify whether the absence of ASPP2 influences NF-κB-regulated target genes, we conducted genome-wide mapping of NF-κB binding sites in the WT and APKO DEN-induced HCC groups by ChIP-Seq. Here, TP53BP2 is linked to hepatocellular carcinoma.